nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—SCN10A—nerve—acquired immunodeficiency syndrome	0.0211	0.0927	CbGeAlD
Procaine—HTR3A—nerve—acquired immunodeficiency syndrome	0.0195	0.0859	CbGeAlD
Procaine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.0162	0.0715	CbGeAlD
Procaine—GRIN3A—nervous system—acquired immunodeficiency syndrome	0.00838	0.0369	CbGeAlD
Procaine—BCHE—blood plasma—acquired immunodeficiency syndrome	0.00819	0.0361	CbGeAlD
Procaine—GRIN3A—central nervous system—acquired immunodeficiency syndrome	0.00806	0.0355	CbGeAlD
Procaine—CHRNA2—blood—acquired immunodeficiency syndrome	0.00757	0.0333	CbGeAlD
Procaine—GRIN3A—brain—acquired immunodeficiency syndrome	0.0064	0.0282	CbGeAlD
Procaine—SCN10A—lymphoid tissue—acquired immunodeficiency syndrome	0.0062	0.0273	CbGeAlD
Procaine—CHRNA2—nervous system—acquired immunodeficiency syndrome	0.00614	0.027	CbGeAlD
Procaine—CHRNA2—central nervous system—acquired immunodeficiency syndrome	0.00591	0.026	CbGeAlD
Procaine—SCN10A—blood—acquired immunodeficiency syndrome	0.00583	0.0257	CbGeAlD
Procaine—HTR3A—digestive system—acquired immunodeficiency syndrome	0.00568	0.025	CbGeAlD
Procaine—SCN10A—spinal cord—acquired immunodeficiency syndrome	0.00562	0.0247	CbGeAlD
Procaine—HTR3A—blood—acquired immunodeficiency syndrome	0.00541	0.0238	CbGeAlD
Procaine—SCN10A—lung—acquired immunodeficiency syndrome	0.00511	0.0225	CbGeAlD
Procaine—HTR3A—lung—acquired immunodeficiency syndrome	0.00474	0.0209	CbGeAlD
Procaine—SCN10A—nervous system—acquired immunodeficiency syndrome	0.00474	0.0208	CbGeAlD
Procaine—CHRNA2—brain—acquired immunodeficiency syndrome	0.0047	0.0207	CbGeAlD
Procaine—SCN10A—central nervous system—acquired immunodeficiency syndrome	0.00456	0.0201	CbGeAlD
Procaine—HTR3A—nervous system—acquired immunodeficiency syndrome	0.00439	0.0193	CbGeAlD
Procaine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.00434	0.0191	CbGeAlD
Procaine—HTR3A—central nervous system—acquired immunodeficiency syndrome	0.00423	0.0186	CbGeAlD
Procaine—SLC6A3—lung—acquired immunodeficiency syndrome	0.00394	0.0174	CbGeAlD
Procaine—BCHE—skin of body—acquired immunodeficiency syndrome	0.00394	0.0173	CbGeAlD
Procaine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.00365	0.0161	CbGeAlD
Procaine—SCN10A—brain—acquired immunodeficiency syndrome	0.00362	0.0159	CbGeAlD
Procaine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.00352	0.0155	CbGeAlD
Procaine—SCN10A—lymph node—acquired immunodeficiency syndrome	0.0035	0.0154	CbGeAlD
Procaine—HTR3A—brain—acquired immunodeficiency syndrome	0.00336	0.0148	CbGeAlD
Procaine—BCHE—digestive system—acquired immunodeficiency syndrome	0.00315	0.0139	CbGeAlD
Procaine—BCHE—blood—acquired immunodeficiency syndrome	0.003	0.0132	CbGeAlD
Procaine—BCHE—bone marrow—acquired immunodeficiency syndrome	0.0029	0.0128	CbGeAlD
Procaine—BCHE—spinal cord—acquired immunodeficiency syndrome	0.00289	0.0127	CbGeAlD
Procaine—SLC6A3—brain—acquired immunodeficiency syndrome	0.00279	0.0123	CbGeAlD
Procaine—BCHE—vagina—acquired immunodeficiency syndrome	0.00278	0.0122	CbGeAlD
Procaine—BCHE—lung—acquired immunodeficiency syndrome	0.00263	0.0116	CbGeAlD
Procaine—BCHE—nervous system—acquired immunodeficiency syndrome	0.00244	0.0107	CbGeAlD
Procaine—BCHE—central nervous system—acquired immunodeficiency syndrome	0.00234	0.0103	CbGeAlD
Procaine—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00187	0.00242	CcSEcCtD
Procaine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00186	0.00241	CcSEcCtD
Procaine—BCHE—brain—acquired immunodeficiency syndrome	0.00186	0.0082	CbGeAlD
Procaine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00186	0.00241	CcSEcCtD
Procaine—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.00186	0.00241	CcSEcCtD
Procaine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00186	0.0024	CcSEcCtD
Procaine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00185	0.0024	CcSEcCtD
Procaine—Syncope—Indinavir—acquired immunodeficiency syndrome	0.00185	0.00239	CcSEcCtD
Procaine—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.00185	0.00239	CcSEcCtD
Procaine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00184	0.00238	CcSEcCtD
Procaine—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00183	0.00237	CcSEcCtD
Procaine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00183	0.00236	CcSEcCtD
Procaine—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.00181	0.00235	CcSEcCtD
Procaine—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.00181	0.00234	CcSEcCtD
Procaine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00181	0.00234	CcSEcCtD
Procaine—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00181	0.00234	CcSEcCtD
Procaine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.0018	0.00233	CcSEcCtD
Procaine—BCHE—lymph node—acquired immunodeficiency syndrome	0.0018	0.00792	CbGeAlD
Procaine—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.0018	0.00232	CcSEcCtD
Procaine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.00179	0.00232	CcSEcCtD
Procaine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00178	0.0023	CcSEcCtD
Procaine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00178	0.0023	CcSEcCtD
Procaine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.00178	0.0023	CcSEcCtD
Procaine—Chills—Ritonavir—acquired immunodeficiency syndrome	0.00178	0.0023	CcSEcCtD
Procaine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00177	0.00229	CcSEcCtD
Procaine—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00177	0.00229	CcSEcCtD
Procaine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00177	0.00229	CcSEcCtD
Procaine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00176	0.00227	CcSEcCtD
Procaine—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00176	0.00227	CcSEcCtD
Procaine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00175	0.00226	CcSEcCtD
Procaine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00175	0.00226	CcSEcCtD
Procaine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.00175	0.00226	CcSEcCtD
Procaine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.00175	0.00226	CcSEcCtD
Procaine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.00171	0.00222	CcSEcCtD
Procaine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00171	0.00222	CcSEcCtD
Procaine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.00171	0.00222	CcSEcCtD
Procaine—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00171	0.00221	CcSEcCtD
Procaine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00171	0.00221	CcSEcCtD
Procaine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.0017	0.0022	CcSEcCtD
Procaine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.0017	0.0022	CcSEcCtD
Procaine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00169	0.00219	CcSEcCtD
Procaine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00169	0.00218	CcSEcCtD
Procaine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00168	0.00218	CcSEcCtD
Procaine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00168	0.00218	CcSEcCtD
Procaine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00168	0.00218	CcSEcCtD
Procaine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00167	0.00217	CcSEcCtD
Procaine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00167	0.00216	CcSEcCtD
Procaine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00167	0.00216	CcSEcCtD
Procaine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00167	0.00216	CcSEcCtD
Procaine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.00215	CcSEcCtD
Procaine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00166	0.00215	CcSEcCtD
Procaine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00166	0.00215	CcSEcCtD
Procaine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00166	0.00215	CcSEcCtD
Procaine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00166	0.00214	CcSEcCtD
Procaine—Shock—Indinavir—acquired immunodeficiency syndrome	0.00166	0.00214	CcSEcCtD
Procaine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00165	0.00214	CcSEcCtD
Procaine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00165	0.00214	CcSEcCtD
Procaine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00165	0.00214	CcSEcCtD
Procaine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00165	0.00213	CcSEcCtD
Procaine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00165	0.00213	CcSEcCtD
Procaine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00165	0.00213	CcSEcCtD
Procaine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00164	0.00212	CcSEcCtD
Procaine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00164	0.00212	CcSEcCtD
Procaine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00163	0.00211	CcSEcCtD
Procaine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00163	0.00211	CcSEcCtD
Procaine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00163	0.00211	CcSEcCtD
Procaine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00162	0.0021	CcSEcCtD
Procaine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00162	0.0021	CcSEcCtD
Procaine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00162	0.00209	CcSEcCtD
Procaine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00161	0.00208	CcSEcCtD
Procaine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00161	0.00208	CcSEcCtD
Procaine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00159	0.00206	CcSEcCtD
Procaine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00159	0.00205	CcSEcCtD
Procaine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00158	0.00205	CcSEcCtD
Procaine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00158	0.00205	CcSEcCtD
Procaine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00158	0.00205	CcSEcCtD
Procaine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00156	0.00202	CcSEcCtD
Procaine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00156	0.00202	CcSEcCtD
Procaine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00156	0.00202	CcSEcCtD
Procaine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00156	0.00201	CcSEcCtD
Procaine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00155	0.00201	CcSEcCtD
Procaine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00155	0.00201	CcSEcCtD
Procaine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00155	0.00201	CcSEcCtD
Procaine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00155	0.002	CcSEcCtD
Procaine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00154	0.002	CcSEcCtD
Procaine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00154	0.00199	CcSEcCtD
Procaine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00154	0.00199	CcSEcCtD
Procaine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00154	0.00199	CcSEcCtD
Procaine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00153	0.00199	CcSEcCtD
Procaine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00153	0.00198	CcSEcCtD
Procaine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00153	0.00197	CcSEcCtD
Procaine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00153	0.00197	CcSEcCtD
Procaine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00153	0.00197	CcSEcCtD
Procaine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00152	0.00197	CcSEcCtD
Procaine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00152	0.00196	CcSEcCtD
Procaine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00151	0.00196	CcSEcCtD
Procaine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00151	0.00196	CcSEcCtD
Procaine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00151	0.00196	CcSEcCtD
Procaine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.00194	CcSEcCtD
Procaine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00194	CcSEcCtD
Procaine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00149	0.00193	CcSEcCtD
Procaine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00149	0.00193	CcSEcCtD
Procaine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00149	0.00193	CcSEcCtD
Procaine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00149	0.00193	CcSEcCtD
Procaine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00149	0.00192	CcSEcCtD
Procaine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00149	0.00192	CcSEcCtD
Procaine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00192	CcSEcCtD
Procaine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00148	0.00191	CcSEcCtD
Procaine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00148	0.00191	CcSEcCtD
Procaine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00147	0.00191	CcSEcCtD
Procaine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00147	0.0019	CcSEcCtD
Procaine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00147	0.0019	CcSEcCtD
Procaine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00146	0.00189	CcSEcCtD
Procaine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00146	0.00189	CcSEcCtD
Procaine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00145	0.00188	CcSEcCtD
Procaine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00145	0.00188	CcSEcCtD
Procaine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00187	CcSEcCtD
Procaine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00145	0.00187	CcSEcCtD
Procaine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00144	0.00186	CcSEcCtD
Procaine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00144	0.00186	CcSEcCtD
Procaine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00143	0.00185	CcSEcCtD
Procaine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00143	0.00185	CcSEcCtD
Procaine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00143	0.00185	CcSEcCtD
Procaine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00142	0.00184	CcSEcCtD
Procaine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00142	0.00184	CcSEcCtD
Procaine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00142	0.00184	CcSEcCtD
Procaine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00142	0.00184	CcSEcCtD
Procaine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00142	0.00183	CcSEcCtD
Procaine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00141	0.00183	CcSEcCtD
Procaine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.00183	CcSEcCtD
Procaine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.00182	CcSEcCtD
Procaine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00141	0.00182	CcSEcCtD
Procaine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0014	0.00182	CcSEcCtD
Procaine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00139	0.0018	CcSEcCtD
Procaine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00139	0.00179	CcSEcCtD
Procaine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00179	CcSEcCtD
Procaine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00138	0.00179	CcSEcCtD
Procaine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00178	CcSEcCtD
Procaine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00138	0.00178	CcSEcCtD
Procaine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00137	0.00178	CcSEcCtD
Procaine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00137	0.00177	CcSEcCtD
Procaine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00137	0.00177	CcSEcCtD
Procaine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00137	0.00177	CcSEcCtD
Procaine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00136	0.00176	CcSEcCtD
Procaine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00136	0.00176	CcSEcCtD
Procaine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00136	0.00176	CcSEcCtD
Procaine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00136	0.00176	CcSEcCtD
Procaine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00135	0.00175	CcSEcCtD
Procaine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00135	0.00175	CcSEcCtD
Procaine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00135	0.00174	CcSEcCtD
Procaine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00134	0.00174	CcSEcCtD
Procaine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00134	0.00173	CcSEcCtD
Procaine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00133	0.00172	CcSEcCtD
Procaine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00172	CcSEcCtD
Procaine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00133	0.00172	CcSEcCtD
Procaine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00133	0.00172	CcSEcCtD
Procaine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00132	0.00171	CcSEcCtD
Procaine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00132	0.0017	CcSEcCtD
Procaine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00132	0.0017	CcSEcCtD
Procaine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00131	0.0017	CcSEcCtD
Procaine—Rash—Stavudine—acquired immunodeficiency syndrome	0.00131	0.0017	CcSEcCtD
Procaine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00131	0.0017	CcSEcCtD
Procaine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00131	0.0017	CcSEcCtD
Procaine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00131	0.00169	CcSEcCtD
Procaine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.0013	0.00169	CcSEcCtD
Procaine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00129	0.00167	CcSEcCtD
Procaine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00129	0.00167	CcSEcCtD
Procaine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00167	CcSEcCtD
Procaine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00167	CcSEcCtD
Procaine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00166	CcSEcCtD
Procaine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00128	0.00166	CcSEcCtD
Procaine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00128	0.00166	CcSEcCtD
Procaine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00164	CcSEcCtD
Procaine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00127	0.00164	CcSEcCtD
Procaine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00164	CcSEcCtD
Procaine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.00163	CcSEcCtD
Procaine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.00163	CcSEcCtD
Procaine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00162	CcSEcCtD
Procaine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.00162	CcSEcCtD
Procaine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00124	0.00161	CcSEcCtD
Procaine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00124	0.0016	CcSEcCtD
Procaine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.0016	CcSEcCtD
Procaine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00124	0.0016	CcSEcCtD
Procaine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.0016	CcSEcCtD
Procaine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00122	0.00158	CcSEcCtD
Procaine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00121	0.00157	CcSEcCtD
Procaine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00156	CcSEcCtD
Procaine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00121	0.00156	CcSEcCtD
Procaine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.0012	0.00156	CcSEcCtD
Procaine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.00156	CcSEcCtD
Procaine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.0012	0.00155	CcSEcCtD
Procaine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00119	0.00154	CcSEcCtD
Procaine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.00152	CcSEcCtD
Procaine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00152	CcSEcCtD
Procaine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00117	0.00151	CcSEcCtD
Procaine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00149	CcSEcCtD
Procaine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00115	0.00149	CcSEcCtD
Procaine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00149	CcSEcCtD
Procaine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00114	0.00148	CcSEcCtD
Procaine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00114	0.00148	CcSEcCtD
Procaine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00146	CcSEcCtD
Procaine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.00145	CcSEcCtD
Procaine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00145	CcSEcCtD
Procaine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00144	CcSEcCtD
Procaine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00111	0.00144	CcSEcCtD
Procaine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00144	CcSEcCtD
Procaine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00141	CcSEcCtD
Procaine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00139	CcSEcCtD
Procaine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00108	0.00139	CcSEcCtD
Procaine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00108	0.00139	CcSEcCtD
Procaine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00139	CcSEcCtD
Procaine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00107	0.00138	CcSEcCtD
Procaine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00137	CcSEcCtD
Procaine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00137	CcSEcCtD
Procaine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00136	CcSEcCtD
Procaine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00135	CcSEcCtD
Procaine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00134	CcSEcCtD
Procaine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00133	CcSEcCtD
Procaine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00132	CcSEcCtD
Procaine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00131	CcSEcCtD
Procaine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.0013	CcSEcCtD
Procaine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.001	0.0013	CcSEcCtD
Procaine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.001	0.0013	CcSEcCtD
Procaine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.001	0.00129	CcSEcCtD
Procaine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000998	0.00129	CcSEcCtD
Procaine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000996	0.00129	CcSEcCtD
Procaine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000968	0.00125	CcSEcCtD
Procaine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000963	0.00125	CcSEcCtD
Procaine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000959	0.00124	CcSEcCtD
Procaine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000959	0.00124	CcSEcCtD
Procaine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000958	0.00124	CcSEcCtD
Procaine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000952	0.00123	CcSEcCtD
Procaine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000945	0.00122	CcSEcCtD
Procaine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000931	0.0012	CcSEcCtD
Procaine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000927	0.0012	CcSEcCtD
Procaine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000914	0.00118	CcSEcCtD
Procaine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000904	0.00117	CcSEcCtD
Procaine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000896	0.00116	CcSEcCtD
Procaine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000895	0.00116	CcSEcCtD
Procaine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000887	0.00115	CcSEcCtD
Procaine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000886	0.00115	CcSEcCtD
Procaine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000884	0.00114	CcSEcCtD
Procaine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000861	0.00111	CcSEcCtD
Procaine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000854	0.00111	CcSEcCtD
Procaine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000854	0.0011	CcSEcCtD
Procaine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000853	0.0011	CcSEcCtD
Procaine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000836	0.00108	CcSEcCtD
Procaine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000822	0.00106	CcSEcCtD
Procaine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000815	0.00105	CcSEcCtD
Procaine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000814	0.00105	CcSEcCtD
Procaine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000805	0.00104	CcSEcCtD
Procaine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000767	0.000993	CcSEcCtD
